Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
26%
OVERLAP
BY WEIGHT
45
# OF OVERLAPPING
HOLDINGS
IBB
247
HOLDINGS
21%
ALSO IN WDNA
WDNA
85
HOLDINGS
54%
ALSO IN IBB
SECTOR DRIFT (IBB minus WDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 4.7% | 3.0% | 3.0% |
|
NATERA INC | 2.6% | 4.4% | 2.6% |
|
GILEAD SCIENCES INC | 7.1% | 1.9% | 1.9% |
|
UNITED THERAPEUTICS CORP | 1.8% | 2.2% | 1.8% |
|
VERTEX PHARMACEUTICALS INC | 7.1% | 1.5% | 1.5% |
IBB Overweight Relative to WDNA
|
AMGEN INC | 6.2% |
|
REGENERON PHARMACEUTICALS | 5.7% |
|
VERTEX PHARMACEUTICALS INC | 5.6% |
|
GILEAD SCIENCES INC | 5.3% |
|
INSMED INC | 3.6% |
|
IQVIA HOLDINGS INC | 3.2% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.5% |
 |
ARGENX SE ADR | 2.1% |
|
WATERS CORP | 2.0% |
|
BEIGENE LTD. SPONSORED ADR | 1.8% |
IBB Underweight Relative to WDNA
|
BLUEPRINT MEDICINES CORP. | -3.8% |
 |
NOVOZYMES A/S-B SHARES | -3.2% |
|
BRIDGEBIO PHARMA, INC. | -3.0% |
|
ELI LILLY & CO | -2.3% |
|
STOKE THERAPEUTICS, INC. | -2.2% |
|
AGIOS PHARMACEUTICALS INC | -2.0% |
|
TWIST BIOSCIENCE CORP. | -2.0% |
|
NOVARTIS AG | -1.9% |
|
NATERA INC | -1.8% |
|
VERACYTE INC | -1.8% |